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Maytenus ilicifolia is a native plant from South America, 
with several medicinal properties including antioxidant 
effects. Aim: using an original cisplatin induced ototoxicity 
model, we evaluated a possible otoprotection caused by 
Maytenus ilicifolia extract. Materials and methods: clinical 
and experimental study design with female albino guinea pigs 
divided in groups as follows: 9 animals receiving cisplatin 
only (three doses of 7.5mg/kg/day), 4 animals receiving 
the plant extract only, 10 animals receiving the cisplatin 
protocol and 1g/kg/day of extract for 8 days, 5 animals with 
cisplatin and 3g/kg/day of extract for 8 days, and 5 animals 
receiving extract for 3 weeks and cisplatin in the last week. 
The tests were distortion product otoacoustic emissions, 
brainstem auditory response, before and after medication and 
scanning electron microscopy. Results: the animals receiving 
cisplatin plus plant extract, had alterations in all the tests, 
showing lesions on the basal cochlear region under electron 
microscopy. Conclusions: Despite of the plant extract’s 
antioxidant effect, it was not sufficient to protect the cochlea 
against cisplatin ototoxicity.
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INTRODUCTION
A major challenge for Otology in this century has 
been the treatment of sensorial dysacusis; this condition 
has become more frequent due to noise exposure, aging 
and use of medication, among other causes. Recent studies 
of medicinal plants1-3 have attracted the attention of our 
group in finding otoprotecting properties to attenuate or 
avoid cochlear injury.
Maytenus ilicifolia is a native plant in many regions 
of South America, including southeast Brazil. This plant 
has various possible medicinal actions including analgesic, 
anti-inflammatory,1 antitumor, antiulcer2 and antioxidan-
ting3 effects. We chose Maytenus ilicifolia to investigate its 
possible otoprotective effects because it has antioxydating 
properties (presence of flavonoids and alkaloids),4,5 few 
side effects in human beings, and minimizes the toxic 
action of a variety of agents.6-8
We chose cisplatin for producing cochlear injuries. 
This drug is an important chemotherapy agent for the tre-
atment of solid tumors in adults and children; it may cause 
(often irreversible) auditory injury and is nephrotoxic,9 
also causing significant gastrointestinal and neurological 
side effects.10,11 Cisplatin injures various cochlear structures 
including hair cells, supporting cells, the vascular striae and 
the auditory nerve.12,13 Cisplatin produces free radicals that 
affect the antioxidative cell system, leading to cell death.14 
The degree of injury depends on the dose and administra-
tion route.12 We tested a few ototoxicity protocols in guinea 
pigs,15-17 but did not encounter the injury level described 
in some of these protocols,17 or there was a high mortality 
rate with ototoxic doses.16 For this reason we developed 
an original protocol which yielded injury in three cochlear 
gyri, ratified by otoacoustic emission distortion product 
tests (OAEDP), the brainstem auditory evoked potential 
(BAEP) and scanning electron microscopy (EM); this pro-
tocol had a lower lethality rate. The ideal dose was 22.5 
mg/kg given intraperitoneally, divided into three doses, 
spaced five days between the first and second dose and 
one day between the last doses.18
The purpose of this study was to verify by function 
tests any possible otoprotective action provided by the 
aqueous extract of Maytenus ilicifolia in cisplatin-treated 
guinea pigs.
METHOD
The Research Ethics Committee of our university 
approved this clinical and experimental study (number 
1461/04). The animals were 3 to 4 month female albino 
guinea pigs weighing from 350 to 450g. The choice of 
sex, weight and lack of pigmentation was based on clini-
cal observation and data in the literature19 on sensitivity, 
cisplatin ototoxicity, and increased animal survival and 
test response uniformity. All animals were healthy and 
had normal otoscopies.
 
Obtaining the Aqueous Extract of Maytenus ilicifolia
The Centro de Pesquisas Químicas, Biológicas e 
Agrícolas provided the Maytenus ilicifolia extract. The 
species is cultivated in this center by doctors Pedro Mellilo 
Magalhães and Ílio Montanari Júnior under controlled soil 
fertility, humidity, sunlight, temperature, and herbivore 
and soil pollution agricultural conditions.
The Maytenus ilicifolia leaf powder was extracted by 
infusion (5%, 50 g/l) in water during 30 minutes at 73ºC. 
The resulting liquid was filtered, concentrated to 150 ml 
in a vacuum evaporator at 50ºC and freeze-dried to yield 
the aqueous extract of Maytenus ilicifolia.
 
Assessment of Auditory Function
All animals underwent BAEP and OAEDP testing 
to measure auditory thresholds and the wholeness of the 
outer hair cells (OHCs). The test device was a Bio-logic, 
Navigator-Pro and Audix model. Guinea pigs were seda-
ted with xylazine (10 mg/kg) and ketamine chloridrate 
(40 mg/kg).
The test environment was acoustically adequate 
and the electrodes were placed over the mastoid region 
of each ear and the vertex of the head; earphones were 
placed over the corresponding ears.
A monochannel click stimulus was used for BAEP 
testing (0.1 to 1.5 kHz filter, 10.66ms window, 100ms click 
duration, 13.3 times per second stimulus rate, 50,000 mean 
gain, visualized on an oscilloscope). Analyzed frequencies 
were 1 to 3 kHz. The threshold was defined as the lowest 
intensity that reproduced wave deflection tracings. Res-
ponses were given in SPL (sound pressure level).
We used the OAEDP as it is a highly sensitive test 
for cisplatin-provoked OHC injury.15,16 Responses were 
analyzed at 500, 1, 2, 3, 4 and 8 kHz, with L1 and L2 from 
65 to 55 SPL intensities respectively, and a 1.2 F1/F2 ratio. 
A probe for emitting sounds (f1 and f2) was placed over 
the ear that was being tested until a response was obtained. 
We compared the parameters background noise (NF) and 
the response (DP), and analyzed the difference (DP-NF) 
before and after the treatment.
Guinea pigs that had prior altered tests were exclu-
ded from the study.
 
Scanning Electron Microscopy Investigation
Scanning electron microscopy was done on the 
animals to demonstrate the cisplatin-induced OHC injuries, 
particularly in the basal gyrus16 and to observe possible 
morphological changes in the animals treated with the 
aqueous extract.
At the end of treatment the animals were sacrificed 
using a lethal injection of the anesthetic (ketamine), then 
decapitated for microsurgical cochlear dissection.
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The cochlear was fixated by the perfusion technique 
using a 2.5% glutaraldehyde solution, and buffered to pH 
7.4 with acetate during 24 hours; a sufficient amount was 
injected into the round window until perilymph exited the 
apex. The material was then placed in a buffered sodium 
cacodilate 0.1 M, ph 7.2 solution during 12 hours. Ethanol 
dehydration was done increasing its concentration from 
50% to 100%, in steps of 30 minutes. The critical point was 
done during 60 minutes, and a gold bath was done during 
one hour. The samples were placed in supports and fixated 
with enamel for visualization in a JEOL model 5300 EM 
device, at 1500 and 2000X magnifications. We observed 
the three OHC layers and one inner hair cell layer in three 
and a half gyri; we chose those areas with fewer artifacts 
and less tissue loss. Gyri were glued separately and the 
areas that were difficult to visualize were discarded.
 
Treatment
The groups were divided as follows:
Group 1: 10 guinea pigs (20 ears) were given 3 
doses of cisplatin (7.5 mg/kg/d) on the 1st, 5th and 6th 
days.
Group 2: 10 guinea pigs (20 ears) were given only 
the aqueous extract (3 g/kg/d) daily for 7 days.
Group 3: 10 guinea pigs (20 ears) were given the 
aqueous extract (1 g/kg/d) daily for 7 days and 3 doses 
of cisplatin.
Group 4: 5 guinea pigs (10 ears) were given the 
aqueous extract (3 g/kg/d) daily for 7 days and 3 doses 
of cisplatin.
Group 5: 5 guinea pigs (10 ears) were given the 
aqueous extract (1g/kg/d) for 3 weeks and 3 doses of 
cisplatin in the last week.
The guinea pigs were sacrificed 24 hours after the 
last dose of cisplatin. The oral extract was given per os 
after a 4-hour fasting period, once daily, starting one day 
before the first dose of cisplatin.
BAEP and OAEDP testing were done before starting 
the medication and 24 hours after the last dose. Weight 




The data for each ear of each guinea pig were 
analyzed separately as a single datum, after which data 
was grouped; the reason for this was that each ear had di-
fferent responses in the test and there was inter-individual 
variation within normal limits, particularly with OAEDP 
testing.
The ANOVA test was used for analyzing BAEP test 
results; the significance level was 5%. The chi-square test 
was used for analyzing OAEDP test results; the significance 




Table 1 shows the means for DP differences before 
and after the treatment, including the statistical test results. 
The group treated only with the aqueous extract (group 2) 
showed statistically significant differences in all frequency 
values (p<0.001) compared to the group treated only with 
cisplatin (group 1). We found that there were statistical 
differences between the groups treated with the aqueous 
extract and cisplatin only at the geometric mean values 
of 7206, 5434 and 2730 (groups 3,4 and 5) compared to 
group 1 (only cisplatin); these differences were not found 
in the other five frequencies.
Table 1. Mean DP-NF values (pre- minus DP-NF) following treatment in each group according to geometric mean of frequencies (geometric 
mean).
Frequencies (geometric mean)
Groups 7206 5434 3616 2730 1818 1352 886 676
1 37,33 35 15,5 23 18 4 7,67 7
2 -11.6 -2.1 -1.5 -4.6 -0.9 -1.4 4.2 -1.2
3 52,0 40,0 31,0 21,3 16,3 19,3 1,5 10,0
4 28,0 21,6 22,3 16,0 21,0 4,0 24,0 6,7
5 18 23,10 20,5 28 21 6,67 14 7,7
p < 0.001 0.018 0.14 0.001 0.694 0.40 0.572 0.230
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BAEP
Table 2 shows the pre- and post-medication test 
results. The mean (M) and the standard deviation (SD) 
are shown.
Group 1 showed a statistically significant threshold 
increase (p<0.001) following medication compared to the 
group that was given only the aqueous extract (group 2). 
There were no statistically significant differences between 
the responses of groups 3,4 and 5 (groups given cisplatin 
and the aqueous extract) and that of group 1 (only cis-
platin) (p=0.31).
Table 2. Mean value and SD of PTE before and after the treatment 
(M - mean; SD - standard deviation).
Groups
1 2 * 3** 4** 5**
Mean    90 42 98 89 91
SD 16,8 7 14 11 15
n 18 10 20 10 10
*p < 0.001 (group 1 x group 2) 
** p= 0.31 (group 1 x groups 3, 4 and 5)
 
Scanning electron microscopy
The morphological investigation showed that there 
was severe injury (over 70% loss of OHCs) and complete 
(100%) loss of OHCs observed by scanning electron mi-
croscopy in some guinea pigs in the middle (and mostly) 
the basal gyri of guinea pigs treated only with cisplatin 
(Figure 1). Guinea pigs treated with the aqueous extract, 
regardless of the dose, showed severe injuries, but with 
preservation of some OHCs.
Figure 1 shows an EM image of a group 1 guinea pig 
in which extensive OHC injury is seen in the basal gyrus. 
Figure 2 shows an EM image of OHCs from group 2 guinea 
pigs in which anatomical structures are preserved.
Figure 1. Scanning electron microscopy of a group 1 animal. Note 
extensive OHC injury in the basal portion of the cochlea. Scale = 
10µM; 1500X magnification.
Figure 2. Scanning electron microscopy of a group 2 animal. Note 
preserved cilia in OHCs in the basal portion of the cochlea. Scale = 
10µM; 2000X magnification.
Figure 3. Scanning electron microscopy of a group 3 animal (EA and 
cisplatin treated). Note extensive OHC injury in the basal portion of the 
cochlea. Scale = 10µM; 2000X magnification.
Figure 4. Scanning electron microscopy of a group 4 animal (EA and 
cisplatin treated - 3g/d). Note less intense OHC injury in the basal 
portion of the cochlea. Scale = 10µM; 2000X magnification.
Maytenus ilicifolia in the prevention of cisplatin-induced ototoxicity.
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Figures 3, 4 and 5 are images of basal gyri OHCs 
from groups 3, 4 and 5 guinea pigs, showing large areas 
in which hair cells are absent and preservation of some 
cells and anatomical structures.
it inhibits the lipoperoxidation process in rat brains by 
producing reactive species (antioxidant agents).
Oliveira et al.22 studied plasma red blood cells and 
proteins using radioactive technetium and found that 
there appeared to be antioxidant agents in the extract of 
this plant.
Melo et al.23 induced free radical production in 
E. Coli type bacteria previously treated with SnCl2 and 
compared the antioxidant properties of Maytenus ilicifo-
lia, Cymbopogon citratus, and Baccharis genistelloides. 
Maytenus had the best effect of the three plants.
In our study, the aqueous extract of Maytenus ili-
cifloia was given in 1g/d doses during 8 days and 3g/d 
during 8 days, 24 hours before and jointly with cisplatin, 
to verify a possible otoprotective action of this plant due 
to its antioxidant mechanism.
The aqueous extract of Maytenus ilicifloia did not 
block cisplatin-induced OHC injury, regardless of the dose, 
as confirmed by auditory testing. Although the results of 
OAEDP testing showed statistically significant responses at 
some frequencies compared to the cisplatin group, there 
were poor responses at most frequencies. This may be 
explained by observing the scanning EM of some guinea 
pigs in which most of the OHCs were injured, but some 
rows of these cells were still preserved or had structural 
changes with no loss of cilia, suggesting that there may be 
favorable responses at certain OAEDP frequencies.
The aqueous extract also preserved the physical 
status of the animals; these animals had less weight loss 
and lower lethality. The aqueous extract as an antioxidant-
producing drug used prior to cisplatin for otoprotection 
was not effective for preserving the hearing of guinea 
pigs (group 5).
Figure 5. Scanning electron microscopy of a group 5 animal (EA and 
cisplatin treated during 3 weeks). Note extensive OHC injury in the basal 
portion of the cochlea. Scale = 10µM; 2000X magnification.
 
Clinical Status and Weight
The fur of guinea pigs treated jointly with the 
aqueous extract was not bristled, their food and water 
intake was not decreased, they were more active and the 
physical aspect was good. Exceptions were guinea pigs 
treated for three weeks (Table 3).
The mortality of the cisplatin only group (group 
1) was 50%; there was no mortality in groups 2, 4 and 5. 
In group 3, 20% of animals did not survive more than 5 
days.
Table 3. Variation of the mean weight of guinea pigs during the treatment and on the day of euthanasia, and mean loss (-) or gain (+).
Groups 
Mean - 1st day
 (weight g) )
Mean - 5th day 
(weight g)
Mean - 6th day 
(weight  g)
Day of euthanasia 
(weight g) 
Variation (weight g)
1 497.5 469 457.4 427.2 -70.2
2 470.4 486 480.8 49.06 20.2
3 400.5 370 357.5 347.9 -52,6
4 426 411 408 388.6 -37.4
5 531.6 482.8 481.8 456.8 -74.8
DISCUSSION
It is estimated that the Brazilian flora consists of be-
tween 40,000 and 60,000 plant species; it is thus a country 
with a major potential for producing medications. Mayte-
nus ilicifolia has been widely studies, and its medicinal 
effects have been well demonstrated.20-24
Mattei and Carlini11 found that the extract of Mayte-
nus ilicifolia has a significant in vitro antioxidant effect; 
There are some hypotheses for explaining our re-
sults. The aqueous extract of Maytenus ilicifolia appears 
to preserve the clinical status of guinea pigs exposed to 
cisplatin, possibly by an antioxidant action on other organs, 
as weight loss and mortality was clearly different among 
the groups. The metabolism in these organs, however, is 
different from that in the auditory apparatus; the aqueous 
extract of Maytenus ilicifolia was unable to block fully the 
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ototoxic action of cisplatin in auditory organs specifically. A 
second hypothesis is that the aqueous extract of Maytenus 
ilicifolia did not cross the blood-brain barrier, and thus 
did not reach the cochlea; this would explain its effect in 
some organs only. A third hypothesis is that the free radical 
blocking mechanism by the aqueous extract of Maytenus 
ilicifolia was not sufficient to avoid cisplatin injury of the 
Corti organ at the doses used in this study.
CONCLUSION
The aqueous extract of Maytenus ilicifolia did not 
have a sufficient otoprotective effect against cisplatin in this 
study; its use does foster improved physical conditions in 
the animals and decreases the lethality of cisplatin.
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